The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it -- a doctor explains what researchers know about Biogen's Aduhelm
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) |!| Madison
